Literature DB >> 31237451

Differential effects of a 40-hour fast and bile acid supplementation on human GLP-1 and FGF19 responses.

F Samuel van Nierop1, Emma C E Meessen1, Kyra G M Nelissen1, Roos Achterbergh2, Laureen A Lammers3, Frédéric M Vaz4, Ron A A Mathôt3, Heinz-Josef Klümpen5, Steven W Olde Damink6,7, Frank G Schaap6,7, Johannes A Romijn2, E Marleen Kemper3, Maarten R Soeters1.   

Abstract

Bile acids, glucagon-like peptide-1 (GLP-1), and fibroblast growth factor 19 (FGF19) play an important role in postprandial metabolism. In this study, we investigated the postprandial bile acid response in plasma and its relation to insulin, GLP-1, and FGF19. First, we investigated the postprandial response to 40-h fast. Then we administered glycine-conjugated deoxycholic acid (gDCA) with the meal. We performed two separate observational randomized crossover studies on healthy, lean men. In experiment 1: we tested 4-h mixed meal after an overnight fast and a 40-h fast. In experiment 2, we tested a 4-h mixed meal test with and without gDCA supplementation. Both studies measured postprandial glucose, insulin, bile acids, GLP-1, and FGF19. In experiment 1, 40 h of fasting induced insulin resistance and increased postprandial GLP-1 and FGF19 concentrations. After an overnight fast, we observed strong correlations between postprandial insulin and gDCA levels at specific time points. In experiment 2, administration of gDCA increased GLP-1 levels and lowered late postprandial glucose without effect on FGF19. Energy expenditure was not affected by gDCA administration. Unexpectedly, 40 h of fasting increased both GLP-1 and FGF19, where the former appeared bile acid independent and the latter bile acid dependent. Second, a single dose of gDCA increased postprandial GLP-1. Therefore, our data add complexity to the physiological regulation of the enterokines GLP-1 and FGF19 by bile acids.

Entities:  

Keywords:  FGF-19; GLP-1; bile acids; postprandial metabolism; type 2 diabetes

Year:  2019        PMID: 31237451     DOI: 10.1152/ajpendo.00534.2018

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  6 in total

1.  Reduced glycodeoxycholic acid levels are associated with negative clinical outcomes of gestational diabetes mellitus.

Authors:  Bo Zhu; Zhixin Ma; Yuning Zhu; Lei Fang; Hong Zhang; Hongwei Kong; Dajing Xia
Journal:  J Zhejiang Univ Sci B       Date:  2021-03-15       Impact factor: 3.066

Review 2.  The Impact of Fasting on Major Metabolic Pathways of Macronutrients and Pharmacokinetics Steps of Drugs.

Authors:  Reza Karimi; Anita Cleven; Fawzy Elbarbry; Huy Hoang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-01       Impact factor: 2.441

Review 3.  Metabolic Messengers: bile acids.

Authors:  Alessia Perino; Kristina Schoonjans
Journal:  Nat Metab       Date:  2022-03-25

4.  Differential Effects of One Meal per Day in the Evening on Metabolic Health and Physical Performance in Lean Individuals.

Authors:  Emma C E Meessen; Håvard Andresen; Thomas van Barneveld; Anne van Riel; Egil I Johansen; Anders J Kolnes; E Marleen Kemper; Steven W M Olde Damink; Frank G Schaap; Johannes A Romijn; Jørgen Jensen; Maarten R Soeters
Journal:  Front Physiol       Date:  2022-01-11       Impact factor: 4.566

5.  Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study.

Authors:  Annefleur Koopen; Julia Witjes; Koen Wortelboer; Soumia Majait; Andrei Prodan; Evgeni Levin; Hilde Herrema; Maaike Winkelmeijer; Steven Aalvink; Jacques J G H M Bergman; Stephan Havik; Bolette Hartmann; Han Levels; Per-Olof Bergh; Jamie van Son; Manon Balvers; Diogo Mendes Bastos; Erik Stroes; Albert K Groen; Marcus Henricsson; Ellis Marleen Kemper; Jens Holst; Christopher M Strauch; Stanley L Hazen; Fredrik Bäckhed; Willem M De Vos; Max Nieuwdorp; Elena Rampanelli
Journal:  Gut       Date:  2021-10-25       Impact factor: 31.793

6.  Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetes.

Authors:  Suzanne Meiring; Emma C E Meessen; Annieke C G van Baar; Frits Holleman; Max Nieuwdorp; Steven W Olde Damink; Frank G Schaap; Fred M Vaz; Albert K Groen; Maarten R Soeters; Jacques J G H M Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-12-27       Impact factor: 4.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.